Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.
AUTOR(ES)
Ueno, S
RESUMO
A 59 year old man with ischaemic heart disease, developed the clinical and electromyographic changes of the Lambert-Eaton myasthenic syndrome after taking calcium antagonist, diltiazem. The symptoms appeared periodically with a rise and fall in serum level of diltiazem. Extensive search was made for systemic neoplasms and autoimmune diseases without success. Serum antibody to voltage operated calcium channel was not detected.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=489088Documentos Relacionados
- Congenital Lambert-Eaton myasthenic syndrome.
- An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
- Respiratory muscle weakness in the Lambert-Eaton myasthenic syndrome.
- Increased amplitude of F-response in Lambert-Eaton myasthenic syndrome.
- Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome.
